Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
4.25M
-
Shares change
-
+4.2M
-
Total reported value, excl. options
-
$185M
-
Value change
-
+$183M
-
Number of buys
-
62
-
Number of sells
-
-1
-
Price
-
$43.53
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q2 2022
67 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q2 2022.
GSK plc - SPONSORED ADR (GSK) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.25M shares
.
Largest 10 shareholders include CAPTRUST FINANCIAL ADVISORS (1.03M shares), KORNITZER CAPITAL MANAGEMENT INC /KS (697K shares), VAN ECK ASSOCIATES CORP (610K shares), MARSHALL WACE, LLP (429K shares), CAUSEWAY CAPITAL MANAGEMENT LLC (258K shares), KEATING INVESTMENT COUNSELORS INC (176K shares), OAK ASSOCIATES LTD /OH/ (155K shares), Edge Capital Group, LLC (146K shares), MERITAGE PORTFOLIO MANAGEMENT (123K shares), and ZEVIN ASSET MANAGEMENT LLC (70K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.